New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Bio-Rad Laboratories, Inc.
BIO
Shape
US Flag

NYSE

9B

Medical - Devices

Next Earning date - 30 Oct 2024

9B

Medical - Devices

Next Earning date - 30 Oct 2024

324.32USD
Shape4.09 ( 1.28%)
Market Open
favorite-chart

Relative Strenght

8
favorite-chart

Volume Buzz

-96%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

11%

Quote Panel

Shape
Updated October 28, 2024
1W -4.13 % 1M -2.62 % 3M 0.06 % 1Y 20.95 %

Key Metrics

Shape
  • Market Cap

    9.05B


  • Shares Outstanding

    27.90M


  • Share in Float

    23.31M


  • Dividende

    0


  • Earning Date

    30 Oct 2024


  • Price Target

    324.32


  • Average Volume

    298607


  • Beta

    0.947


  • Range

    261.59-364.24


  • Industry

    Medical - Devices


  • Website

    https://www.bio-rad.com


  • Sector

    Healthcare


Fundamentals

Shape

30.08x

P/E Ratio

3.49x

P/S Ratio

1.34x

P/B Ratio

0.2

Debt/Equity

-51.7%

Net Margin

$-47.3

EPS

How BIO compares to sector?

P/E Ratio

Relative Strength

Shape

BIO

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$3B

Shape321%

2025-Revenue

$9.60

Shape113%

2025-EPS

$575M

Shape291%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Citigroup

upgrade

Previous: Neutral

2024-10-01

Now: Buy

Wells Fargo

initialise

Previous: Not converted

2024-08-27

Now: Equal-Weight

Jefferies

downgrade

Previous: Not converted

2024-06-03

Now: Hold

Citigroup

downgrade

Previous: Not converted

2024-04-03

Now: Neutral

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-30%

2.6
vs 3.71

Q4.22

arrow
arrow

+3%

3.31
vs 3.21

Q1.23

arrow
arrow

-32%

3.34
vs 4.94

Q2.23

arrow
arrow

-11%

3
vs 3.38

Q3.23

arrow
arrow

-10%

2.33
vs 2.6

Q4.23

arrow
arrow

-6%

3.1
vs 3.31

Q1.24

arrow
arrow

-31%

2.29
vs 3.34

Q2.24

arrow
arrow

+4%

3.11
vs 3

Q3.24

arrow
arrow

-50%

1.16
vs 2.33

Q4.24

arrow
arrow

-11%

2.77
vs 3.1

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-9%

680.8M  vs 747M

Q4.22

arrow
arrow

0%

730.3M  vs 732.8M

Q1.23

arrow
arrow

-3%

676.8M  vs 700.1M

Q2.23

arrow
arrow

-1%

681.1M  vs 691.1M

Q3.23

arrow
arrow

-7%

632.1M  vs 680.8M

Q4.23

arrow
arrow

-7%

681.2M  vs 730.3M

Q1.24

arrow
arrow

-10%

610.8M  vs 676.8M

Q2.24

arrow
arrow

-6%

638.5M  vs 681.1M

Q3.24

arrow
arrow

-1%

628.2M  vs 632.1M

Q4.24

arrow
arrow

+2%

695.2M  vs 681.2M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-2%

-0.02
vs -0.10

Q4.22

arrow
arrow

+9%

0.09
vs -0.02

Q1.23

arrow
arrow

+1%

0.01
vs 0.09

Q2.23

arrow
arrow

-14%

-0.14
vs 0.01

Q3.23

arrow
arrow

+1%

0.01
vs -0.14

Q4.23

arrow
arrow

+4%

0.04
vs 0.01

Q1.24

arrow
arrow

+4%

0.04
vs 0.04

Q2.24

arrow
arrow

-32%

-0.32
vs 0.04

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

484

484
vs 505

-4%

Q4.22

arrow
arrow

480

480
vs 484

-1%

Q1.23

arrow
arrow

512

512
vs 480

7%

Q2.23

arrow
arrow

473

473
vs 512

-8%

Q3.23

arrow
arrow

470

470
vs 473

-1%

Q4.23

arrow
arrow

491

491
vs 470

4%

Q1.24

arrow
arrow

472

472
vs 491

-4%

Q2.24

arrow
arrow

429

429
vs 472

-9%

Earnings Growth

Latest News